Bortezomib to treat the TEMPI syndrome. Article uri icon

Overview

publication date

  • May 10, 2012

Research

keywords

  • Antineoplastic Agents
  • Boronic Acids
  • Paraproteinemias
  • Polycythemia
  • Pyrazines
  • Telangiectasis

Identity

PubMed Central ID

  • PMC6824588

Scopus Document Identifier

  • 84860740795

Digital Object Identifier (DOI)

  • 10.1056/NEJMc1202649

PubMed ID

  • 22571216

Additional Document Info

volume

  • 366

issue

  • 19